Population scale proteomics accelerates the search for effective new drugs targets

Dr. Chris Whelan discusses how data from the UK Biobank – Pharma Proteomics Project has revealed new insights into associations between gene variants and protein concentrations enabling new causal biomarkers for diseases to be identified as well as new drug targets with higher probabilities of success.